Applications will probably be invited from analysis establishments, PhD students, clinicians, hospitals, startups and incubators working in or adjoining to Ayurveda, plant-based therapeutics and integrative well being. Kapiva mentioned the fund has been structured to help innovation at each stage of improvement, from early analysis to initiatives shut to commercialisation, by providing capital, mentorship and entry to scientific and analysis infrastructure.
Announcing the fund, Ameve Sharma, Founder of Kapiva, mentioned the corporate needs to reposition Ayurveda as an outcome-driven and evidence-backed system of drugs.
“For decades, Ayurveda has been seen as either faith-based or purely traditional wisdom. We believe its future lies in being outcome-led and evidence-backed. This fund is a long-term bet on that future. By investing up to Rs 50 crore in research, collaborations and new technologies, Kapiva wants to help build an ecosystem where Ayurvedic products are developed and tested like modern medicine, yet remain rooted in India’s knowledge systems,” Sharma mentioned.
The innovation fund is now open for functions by way of a devoted portal. Shortlisted proposals will probably be evaluated by Kapiva’s R&D management together with exterior area consultants, based mostly on parameters corresponding to scientific rigour, novelty, feasibility and potential to enhance well being outcomes at scale. The firm mentioned it expects the initiative to play a catalytic function in bridging conventional Ayurvedic data with trendy scientific validation and business utility.
Dr R. Govindarajan, chief innovation officer at Kapiva, mentioned; “If Ayurveda has to sit at the same table as modern medicine, it must be tested with the same discipline. At Kapiva, we already work with standardised extracts, human trials and AI-driven insights that guide our formulations. Through this fund, we want to open that ecosystem to researchers, clinicians and entrepreneurs, share our infrastructure and mentor high-quality projects, so that robust Ayurvedic science can move from paper to products and reach millions of people,” he mentioned.
Kapiva mentioned it already operates one of many extra superior in-house Ayurveda analysis and improvement programmes in the nation, with ongoing scientific trials on flagship merchandise and a devoted analysis crew. The firm collaborates with establishments such because the Translational Health Science and Technology Institute underneath the Ministry of Science and Technology, the Manipal College of Pharmaceutical Sciences and Manipal Hospitals on a number of analysis initiatives.